FDA Approved: ISONIAZID — Supplemental Application (CMP Pharma, Inc.)

View source ↗

Summary

The FDA approved CMP Pharma's supplemental application for isoniazid, authorizing changes to an already approved generic product for tuberculosis under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

SUPPL AP for ISONIAZID (ISONIAZID)